Balyo (BALYO) H1 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2024 earnings summary
13 Jun, 2025Executive summary
H1 2024 sales reached €13.8 million, down 7% year-over-year, with a significant increase in backlog to €17.9 million, up 73% from H1 2023.
Direct order intake rose to 68% of total orders, up from 24% in Q2 2023, with US and APAC markets driving growth.
Gross margin dropped to 21% from 41% in H1 2023, impacted by unfavorable product mix and inventory depreciation.
Net loss widened to €7.4 million from €2.4 million in H1 2023, with operating loss at €7.0 million versus €1.9 million prior year.
Cash position as of June 30, 2024 was €4.7 million, with financial visibility until end of November 2024.
Financial highlights
H1 2024 sales: €13.79 million, down 7% year-over-year; Q2 2024 sales up 12% to €8.5 million.
Gross profit fell 52% to €2.94 million; gross margin rate declined by 20 points to 21%.
Operating expenses increased 25% to €9.95 million, mainly due to higher personnel costs and trade fair participation.
Net loss for H1 2024 was €7.4 million, compared to €2.4 million in H1 2023.
Cash position dropped to €2.4 million by September 24, 2024.
Outlook and guidance
Financial resources expected to fund operations until end of November 2024, with uncertainty about going concern beyond that period.
Plans to launch a €36 million capital increase with preferential subscription rights, subject to shareholder and regulatory approval.
SoftBank intends to support the rights issue and maintain listing for at least 12 months post-transaction.
Latest events from Balyo
- 2025 revenue rose 8% to €31.4M, with US sales up 41% and SoftBank providing key financing.BALYO
H2 202519 Mar 2026 - Gross margin rose to 30% as revenue fell and order backlog surged, but losses continued.BALYO
H1 20251 Oct 2025 - Order intake and backlog surged despite a 4% revenue dip, led by strong US momentum.BALYO
H1 2025 TU17 Jul 2025 - Backlog up 73% to €17.9M, but H1 sales fell 7% and going concern risk remains.BALYO
Q2 2024 TU13 Jun 2025 - 2024 sales up 9% to €29.1M, but net loss deepened as margins declined.BALYO
H2 20246 Jun 2025 - 2024 sales up 9% to €29.1M, fueled by US direct sales and a major capital increase.BALYO
Q4 2024 TU6 Jun 2025